Cargando…
Expression of Osteoprotegerin from a Replicating Adenovirus Inhibits the Progression of Prostate Cancer Bone Metastases in a Murine Model
Metastatic involvement of the skeleton is a frequent consequence of advanced prostate cancer. These skeletal metastases cause a number of debilitating complications and are refractory to current treatments. New therapeutic options are being explored, including conditionally replicating adenoviruses...
Autores principales: | Cody, James J., Rivera, Angel A., Lyons, Gray R., Yang, Sherry W., Wang, Ming, Ashley, Jason W., Meleth, Sreelatha, Feng, Xu, Siegal, Gene P., Douglas, Joanne T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3584184/ https://www.ncbi.nlm.nih.gov/pubmed/23358109 http://dx.doi.org/10.1038/labinvest.2012.179 |
Ejemplares similares
-
Arming a Replicating Adenovirus with Osteoprotegerin Reduces the Tumor Burden in a Murine Model of Osteolytic Bone Metastases of Breast Cancer
por: Cody, James J., et al.
Publicado: (2010) -
Conditionally Replicating Adenovirus Expressing TIMP2 Increases Survival in a Mouse Model of Disseminated Ovarian Cancer
por: Yang, Sherry W., et al.
Publicado: (2011) -
Osteoprotegerin in Bone Metastases: Mathematical Solution to the Puzzle
por: Ryser, Marc D., et al.
Publicado: (2012) -
The case for well-conducted experiments to validate statistical protocols for 2D gels: different pre-processing = different lists of significant proteins
por: Meleth, Sreelatha, et al.
Publicado: (2005) -
Intravenous administration of the conditionally replicative adenovirus Ad5-Δ24RGD induces regression of osteosarcoma lung metastases
por: Graat, Harm CA, et al.
Publicado: (2008)